JAMA 330(15):14721483 Li CW, Osman R, Menconi F, Concepcion E, Tomer Y (2020) Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: therapeutic implications to Graves disease
Potential Adverse Effects of Female and Male Obesity on Fertility: A Narrative Review
The specific dose depends on the patients individual presentation, tolerability, and broader supplement protocol
Who Should Not Undergo This Procedure Based on current clinical understanding, IV glutathione infusions are generally not appropriate for: Individuals who are pregnant or breastfeeding Patients with a history of kidney or liver disease Those with a known allergy to glutathione, ascorbic acid (Vitamin C), or any other component of the infusion Individuals with certain autoimmune or haematological conditions these should be assessed and discussed with a doctor Comparing IV Glutathione to Evidence-Based Skin-Brightening Treatments For patients with concerns about skin tone, hyperpigmentation, melasma, post-inflammatory hyperpigmentation (PIH), or solar lentigines, a range of treatments with a more established evidence base are available in Singapore
10.1080/13813455.2018.1498903 11 BanM.SunY.ChenX.ZhouX.ZhangY.CuiL